330 related articles for article (PubMed ID: 15732870)
1. Treatment of intrabony defects with bovine-derived xenograft alone and in combination with platelet-rich plasma: a randomized clinical trial.
Hanna R; Trejo PM; Weltman RL
J Periodontol; 2004 Dec; 75(12):1668-77. PubMed ID: 15732870
[TBL] [Abstract][Full Text] [Related]
2. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
[TBL] [Abstract][Full Text] [Related]
3. Treatment of intraosseous defects with bioabsorbable barriers alone or in combination with decalcified freeze-dried bone allograft: a randomized clinical trial.
Trejo PM; Weltman R; Caffesse R
J Periodontol; 2000 Dec; 71(12):1852-61. PubMed ID: 11156042
[TBL] [Abstract][Full Text] [Related]
4. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
Velasquez-Plata D; Scheyer ET; Mellonig JT
J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
[TBL] [Abstract][Full Text] [Related]
5. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
[TBL] [Abstract][Full Text] [Related]
6. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
[TBL] [Abstract][Full Text] [Related]
7. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
[TBL] [Abstract][Full Text] [Related]
8. A reentry study on the use of bovine porous bone mineral, GTR, and platelet-rich plasma in the regenerative treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
Int J Periodontics Restorative Dent; 2005 Feb; 25(1):49-59. PubMed ID: 15736778
[TBL] [Abstract][Full Text] [Related]
9. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study.
Paolantonio M
J Periodontol; 2002 Feb; 73(2):158-66. PubMed ID: 11895280
[TBL] [Abstract][Full Text] [Related]
10. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
Batista EL; Novaes AB; Simonpietri JJ; Batista FC
J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
[TBL] [Abstract][Full Text] [Related]
12. Treatment of periodontal endosseous defects with platelet-rich plasma alone or in combination with demineralized freeze-dried bone allograft: a comparative clinical trial.
Markou N; Pepelassi E; Vavouraki H; Stamatakis HC; Nikolopoulos G; Vrotsos I; Tsiklakis K
J Periodontol; 2009 Dec; 80(12):1911-9. PubMed ID: 19961374
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
[TBL] [Abstract][Full Text] [Related]
14. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
[TBL] [Abstract][Full Text] [Related]
15. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results.
Leknes KN; Andersen KM; Bøe OE; Skavland RJ; Albandar JM
J Periodontol; 2009 Feb; 80(2):219-27. PubMed ID: 19186961
[TBL] [Abstract][Full Text] [Related]
16. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Arweiler NB; Gera I; Sculean A
J Periodontol; 2007 Jun; 78(6):983-90. PubMed ID: 17539709
[TBL] [Abstract][Full Text] [Related]
17. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
[TBL] [Abstract][Full Text] [Related]
18. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
[TBL] [Abstract][Full Text] [Related]
19. Platelet-rich fibrin and bovine porous bone mineral vs. platelet-rich fibrin in the treatment of intrabony periodontal defects.
Lekovic V; Milinkovic I; Aleksic Z; Jankovic S; Stankovic P; Kenney EB; Camargo PM
J Periodontal Res; 2012 Aug; 47(4):409-17. PubMed ID: 22126591
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
Gurinsky BS; Mills MP; Mellonig JT
J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
